Inventor · disambiguated record
Debbie Law
Also filed as: LAW DEBBIE
12 granted patents·9 pending applications·112 citations·filing 2001–2013
91Inventor score
Top patents by PatentIndex Score
21 records- 0195US7399469B2Anti-LFL2 antibodies for the diagnosis, prognosis and treatment of cancerPDL BIOPHARMA INC·Filed 2005·Granted Jul 15, 2008·22 cites·10 claims
- 0291US7674883B2Antibodies against cancer antigen TMEFF2 and uses thereofFACET BIOTECH CORP·Filed 2007·Granted Mar 9, 2010·6 cites·14 claims
- 0391US7662384B2Use of anti-α5β1 antibodies to inhibit cancer cell proliferationFACET BIOTECH CORP·Filed 2005·Granted Feb 16, 2010·21 cites·13 claims
- 0491US7288248B2Antibodies against cancer antigen TMEFF2 and uses thereofPDL BIOPHARMA INC·Filed 2003·Granted Oct 30, 2007·27 cites·7 claims
- 0588US8591863B2Compositions against cancer antigen LIV-1 and uses thereofLAW DEBBIE·Filed 2012·Granted Nov 26, 2013·7 cites·18 claims
- 0687US8906342B2Compositions against cancer antigen LIV-1 and uses thereofLAW DEBBIE·Filed 2013·Granted Dec 9, 2014·4 cites·17 claims
- 0787US7807163B2Antibodies against GPR64 and uses thereofFACET BIOTECH CORP·Filed 2008·Granted Oct 5, 2010·7 cites·37 claims
- 0884US7824678B2Antibodies against cancer antigen TMEFF2 and uses thereofFACET BIOTECH CORP·Filed 2007·Granted Nov 2, 2010·4 cites·9 claims
- 0982US7276372B2Antibodies against GPR64 and uses thereofPDL BIOPHARMA INC·Filed 2003·Granted Oct 2, 2007·12 cites·20 claims
- 1081US7785816B2Antibodies against cancer antigen TMEFF2 and uses thereofFACET BIOTECH CORP·Filed 2007·Granted Aug 31, 2010·2 cites·4 claims
- 1168US2010074841A1Compositions Against Cancer Antigen LIV-1 and Uses ThereofFACET BIOTECH CORP·Filed 2009·Application pending·0 cites
- 1268US2008175839A1Compositions Against Cancer Antigen LIV-1 and Uses ThereofPROTEIN DESIGN LABS INC·Filed 2007·Application pending·0 cites
- 1364US7547544B2Antibodies against GPR64 and uses thereofFACET BIOTECH CORP·Filed 2007·Granted Jun 16, 2009·0 cites·18 claims
- 1464US2008171039A1Compositions Against Cancer Antigen Liv-1 and Uses ThereofPROTEIN DESIGN LABS INC·Filed 2007·Application pending·0 cites
- 1562US2004141983A1Compositions against cancer antigen LIV-1 and uses thereofPROTEIN DESIGN LABS INC·Filed 2004·Application pending·0 cites
- 1658US2008260740A1Anti-LFL2 Antibodies for the Diagnosis, Prognosis and Treatment of CancerPDL BIOPHARMA INC·Filed 2008·Application pending·0 cites
- 1758US2010291111A1Use of Anti-Alpha5Beta1 Antibodies to Inhibit Cancer Cell ProliferationFACET BIOTECH·Filed 2009·Application pending·0 cites
- 1853US2005002939A1Tumor killing/tumor regression using CXCR4 antagonistsFiled 2003·Application pending·0 cites
- 1952US8257708B2Antibodies against cancer antigen TMEFF2 and uses thereofBHASKAR VINAY·Filed 2010·Granted Sep 4, 2012·0 cites·21 claims
- 2047US2004223970A1Antibodies against SLC15A2 and uses thereofFiled 2004·Application pending·0 cites
- 2142US2002082206A1Novel polynucleotides from atherogenic cells and polypeptides encoded therebyFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →